| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/05/1997 | CA2236868A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | CA2236794A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/05/1997 | CA2236574A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | CA2235962A1 Use of anti-sense sequences to increase responsiveness to gene amplification |
| 06/04/1997 | EP0776975A2 Method for use of the yeast-ADH-II promotersystem for the biotechnological production of heterologous proteins in high yield |
| 06/04/1997 | EP0776972A1 GENE CODING FOR IgG-Fc-BINDING PROTEIN |
| 06/04/1997 | EP0776969A2 Process to prepare proteins by controlled proteolysis of pro-proteins |
| 06/04/1997 | EP0776907A2 Process for producing platelet factor-4 |
| 06/04/1997 | EP0776906A2 Sm-D peptide antigens and their use especially in the diagnosis of systemic lupus erythromatodes |
| 06/04/1997 | EP0776668A2 Process for the removal of aromatic compounds from solutions |
| 06/04/1997 | EP0776370A1 Human erythropoietin receptor fragment and antibodies thereto |
| 06/04/1997 | EP0776368A2 Protein toxins active against lepidopteran pests |
| 06/04/1997 | EP0776367A1 Dna encoding turkey hypothalamic vasoactive intestinal peptide |
| 06/04/1997 | EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 06/04/1997 | EP0776365A2 Retinoblastoma protein-interacting zinc finger proteins |
| 06/04/1997 | EP0776364A1 Glutamate receptor |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776336A1 Vitronectin binding protein |
| 06/04/1997 | EP0776335A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 06/04/1997 | EP0776334A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776218A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 06/04/1997 | EP0776214A1 Antibacterial composition containing multimeric alpha-lactalbumin |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0776209A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 06/04/1997 | EP0751998A4 A gene expression system utilizing an rna polymerase prebound to dna |
| 06/04/1997 | EP0692967A4 Method of inhibiting radiation induced weight and hair loss |
| 06/04/1997 | EP0672119A4 Retroviral mediated transfer of the human multiple drug resistance gene. |
| 06/04/1997 | EP0666903A4 Insulin-dependent yeast or fungi. |
| 06/04/1997 | EP0552269B1 Platelet adhesion inhibitor |
| 06/04/1997 | EP0545999B1 Process for the preparation of biologically active IGF-1 using IGF-1 having an amino-terminal extension |
| 06/04/1997 | EP0544861A4 Immunoassay for non-a non-b hepatitis |
| 06/04/1997 | EP0527802B1 Ligand for the neu gene product |
| 06/04/1997 | CN1151185A Nucleotide sequences of pestivirus strains, polypeptides encoded by these squences and use thereof for diagnosis and prevention of pestivirus infections |
| 06/04/1997 | CN1151184A Human Monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 06/04/1997 | CN1151183A RPS 2 gene and uses thereof |
| 06/04/1997 | CN1151182A Method for controlling metallophosphate precipitation in high cell density fermentations |
| 06/04/1997 | CN1151168A Method and compositions for the dry powder formulation of interferons |
| 06/04/1997 | CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 06/04/1997 | CN1151120A Method and compositions useful for inhibition of angiogenesis |
| 06/03/1997 | US5635618 Expression construct conferring root specific expresssion in plants comprising regulatory sequence of maize alpha-tubulin consisting of specified nucleotides |
| 06/03/1997 | US5635617 Methods and compositions comprising the agfA gene for detection of Salmonella |
| 06/03/1997 | US5635615 High affinity HIV nucleocapsid nucleic acid ligands |
| 06/03/1997 | US5635606 Contacting sample with an oligosaccharide sequence covalently attached to biogenic inert, solid silicate support through a linker arm, separating support containg toxin a from sample; treats antibiotic related diarrhea |
| 06/03/1997 | US5635604 Amino-terminally extended human growth hormone (HGH) |
| 06/03/1997 | US5635601 Beta-8 integrin subunit antibodies |
| 06/03/1997 | US5635599 Circularly permuted il4, il2, granulocyte macrophage colony stimulating factor or granulocyte colony stimulating factor fused to a cytotoxin, i.e., pseudomonas exotoxin, diphtheria toxin without the native receptor-binding domain; cancer |
| 06/03/1997 | US5635597 Peptides that bind IL-2 receptors |
| 06/03/1997 | US5635596 Useful for detection and diagnosis of hormone dependent breast cancers and stomach cancers or ulcers |
| 06/03/1997 | US5635594 Gallinacins - antibiotic peptides |
| 06/03/1997 | US5635482 Synthetic compounds and compositions with enhanced cell binding |
| 06/03/1997 | US5635481 Administering blood-coagulation factor xai; also for treatment of inflammation and restenosis |
| 06/03/1997 | US5635480 Bacillus thuringiensis isolates and toxins |
| 06/03/1997 | US5635477 Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA |
| 06/03/1997 | US5635475 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 06/03/1997 | US5635473 Inhibitor of hepatitis B virus replication |
| 06/03/1997 | US5635399 Retroviral vectors expressing cytokines |
| 06/03/1997 | US5635389 Antibodies which recognize and bind human villin |
| 06/03/1997 | US5635386 Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
| 06/03/1997 | US5635384 Comprising internal peptide linker sequence by removing the linker, splitting the protein, changing to active form |
| 06/03/1997 | US5635382 Method for enhancing transmembrane transport of exogenous molecules |
| 06/03/1997 | US5635379 Prepared from n-alpha-acetyl-2-alkyl tryptophan racemic mixture |
| 06/03/1997 | US5635374 Bone calcification factor and recombinant production of the factor nucleic acid encoding |
| 06/03/1997 | US5635373 Bone morphogenic protein-5(BMP-5) and DNA encoding same |
| 06/03/1997 | US5635372 BMP-15 compositions |
| 06/03/1997 | US5635371 Modifying dna sequence encoding recombinant polypeptide by adding sequence encoding protecting group having cleavage sequence, removing biologically added protecting group, modifying unprotected terminal amino acid, deprotecting |
| 06/03/1997 | US5635370 DNA encoding BEHAB, a brain hyaluronan-binding protein, and recombinant expression systems for production of BEHAB polypeptides |
| 06/03/1997 | US5635369 Yeast strains with stable integration of heterologous genes |
| 06/03/1997 | US5635363 Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
| 06/03/1997 | US5635360 Detecting with a polynucleotide antibody |
| 06/03/1997 | US5635356 Anti-oncoimmunin-M antibodies and uses thereof |
| 06/03/1997 | US5635355 Methods of obtaining a DNA sequence for integration site independent gene expression |
| 06/03/1997 | US5635354 Method for describing the repertoires of antibodies (Ab) and of T-cell receptors (TcR) of an individual's immune system |
| 06/03/1997 | US5635346 Diagnosing using novel peptide fragments derived from antigens reactive to antibodies present in infected patients |
| 06/03/1997 | US5635345 Isolation of lymphocytes, incubation with labeled monoclonal antibody to a prosomal protein, measuring percentage of cells having this protein on cell surface, comparison with non-infected cells, human immunodeficiency virus, kits |
| 06/03/1997 | US5635188 Serum-free melanoma vaccine obtained by culturing shed human melanoma cell surface antigens |
| 06/03/1997 | US5635182 Method of detecting ligand interactions |
| 06/03/1997 | US5635181 Pure immunogenic peptide encoded by dna sequence present in specified recombinant bacterial plasmid |
| 06/03/1997 | US5635178 Inhibition of complement mediated inflammatory response using monoclonal antibodies specific for a component forming the C56-9 complex which inhibit the platelet or endothelial cell activating function of the C56-9 complex |
| 06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
| 06/03/1997 | US5635175 Treatment of herpes and cytomegalo viruses |
| 06/03/1997 | CA2077651C Peptides stimulating cytotoxic t cells immune to hiv rt |
| 06/02/1997 | CA2164274A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 05/29/1997 | WO1997019194A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE |
| 05/29/1997 | WO1997019183A2 Tissue-specific transcription of dna sequence encoding a heterologous enzyme for use in prodrug therapy to lung cancer |
| 05/29/1997 | WO1997019182A1 Production of retroviral vectors using herpes vectors |
| 05/29/1997 | WO1997019180A2 Vector consisting of a transcriptional regulatory dna sequence linked to a dna sequence encoding beta-lactamase for enzyme prodrug therapy |
| 05/29/1997 | WO1997019179A1 Pseudomonas exotoxin - myelin basic protein chimeric proteins |
| 05/29/1997 | WO1997019178A2 Autoantigenic metal proteases and methods of diagnosing autoimmune diseases |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019173A1 Method of treating sepsis |
| 05/29/1997 | WO1997019172A1 Differentiation-suppressive polypeptide |
| 05/29/1997 | WO1997019171A1 Epithelial membrane protein-1 |
| 05/29/1997 | WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019168A1 Sequestrin |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997019109A1 Trypsin inhibitor protein from pentaclethra macroloba having insecticidal properties |
| 05/29/1997 | WO1997019108A1 Pulmonary surfactant peptide solubilization process |